Editorial Board ::: Pharmaceutical Nanotechnology

ISSN: 2211-7393 (Online)
ISSN: 2211-7385 (Print)


Volume 4, 4 Issues, 2016


Download PDF Flyer




Pharmaceutical Nanotechnology

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Ijeoma F. Uchegbu
Department of Pharmaceutics, University of London
London
UK


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Editorial Board

Editor-in-Chief:

Ijeoma F. Uchegbu (Biography
Ijeoma F. Uchegbu

Ijeoma Uchegbu is Professor of Pharmaceutical Nanoscience at the UCL School of Pharmacy, University College London (UCL), Pro-Vice Provost for Africa and The Middle East, UCL and Chief Scientific Officer of Nanomerics. She obtained her PhD from the School of Pharmacy, University of London in 1994. In 2015, Ijeoma became UCL’s Pro-Vice Provost for Africa and The Middle East. Nanomerics was founded in 2010 by Ijeoma and Andreas G. Schätzlein. Nanomerics is a specialtiy pharmaceutical company focused on exploiting pharmaceutical nanotechnology platforms for medicines development. Ijeoma has been awarded various prizes for her work, notably the UK Department for Business Innovation Skills’ Women of Outstanding Achievement in Science Engineering and Technology award and the Royal Pharmaceutical Society’s Pharmaceutical Scientist of the Year 2012. Ijeoma was elected to the Controlled Release Society College of Fellows in 2013 and became an Eminent Fellow of the Academy of Pharmaceutical Sciences in 2013.

)

Department of Pharmaceutics, University of London
London
UK



Associate Editor(s):

M. Blanco-Prieto (Biography
M. Blanco-Prieto

Maria J. Blanco‐Prieto received her Pharmacy Degree from the University of Santiago de Compostela (Spain), followed by a PhD in Pharmaceutical Sciences from the University of Paris‐Sud (France). She completed a post‐doctoral training at the Swiss Federal Institute of Technology (ETH), Zürich, (Switzerland) and then joined the University of Navarra where presently she is Full Professor of Pharmacy and Pharmaceutical Technology.

Her research lay in the field of biomaterials and advanced drug carrier systems including the design and the development of polymer and lipid based micro‐ and nanoscale carriers, their biological evaluation in in vitro cell cultures (toxicity, mechanism of action, intracellular drug release) and also their pharmacokinetic and dynamic impact in vivo (using relevant animal models of the diseases).

)

University of Navarra
Pamplona
Spain

Huiling Mu (Biography
Huiling Mu

Dr. Mu obtained a doctorate (PhD) in Engineering from Lund University in Sweden and a Master of Science in Chemistry from Nankai University in China. Currently Dr. Mu is an Associate Professor at the Department of Pharmacy, University of Copenhagen in Denmark. She has published more than 120 peer reviewed scientific papers (H-index 30).

)

University of Copenhagen
Copenhagen
Denmark


Regional Editor(s):

F. Dorkoosh (Biography
F. Dorkoosh

Dr. Dorkoosh has received his PhD in pharmaceutics and biopharmaceutics from Leiden University in the Netherlands in 2002. He followed an international training on intellectual property and management of innovation at World Intellectual Property Organization (WIPO) in Geneva, Switzerland in 2005. He got also his Diploma in management from Chartered Management Institute of London, UK in 2009. He is currently an associate professor at Tehran University of Medical Sciences. He is also the head of Patent office of Tehran University of Medical Sciences. Dr. Dorkoosh published more than 80 research articles and held 10 patents and patent applications.

)

Tehran University of Medical Sciences
Tehran
Iran

G.S. Kwon (Biography
G.S. Kwon

Dr. Kwon is the Jens T. Carstensen Distinguished Chair Professor in the School of Pharmacy at University of Wisconsin. He received the Jorge Heller Journal of Controlled Release/Controlled Release Society (CRS) Outstanding Paper Award (1994) and CRS Young Investigator Research Achievement Award (2003). He is a Fellow of the American Association of Pharmaceutical Scientists (2012) and a highly-cited researcher by Thomson Reuters in the category of Pharmacology & Toxicology (2014). He is co-founder of Co-D Therapeutics Inc., a start-up company dedicated to multi-drug anticancer nanotherapeutics.

)

University of Wisconsin
Madison, WI
USA

M. Ramalingam (Biography
M. Ramalingam

Dr. Murugan Ramalingam is Professor at the Centre for Stem Cell Research (India). Concurrently he is Adjunct Professor at the Tohoku University (Japan). He worked as Associate Professor at the Université de Strasbourg (France) and Assistant Professor at the WPI-Advanced Institute for Materials Research (Japan). He has also worked at the U.S. National Institute of Standards and Technology (NIST) and the National Institutes of Health (NIH). He received his Ph.D. in Biomaterials from the University of Madras. He is the author of over 260 scientific publications.

)

Christian Medical College Campus
Vellore
India


Editorial Board Members:

H. Ai
Sichuan University
Chengdu
China

E. Chow
Kemin Industries (Asia) Pte Limited
Singapore

T. Desai
University of California
San Francisco, CA
USA

Z.-W. Gu
Sichuan University
Chengdu
China

A.V. Kabanov
University of Nebraska
Omaha, NE
USA

C. O'Driscoll
University College Cork
Cork
Ireland

M. N. V. Ravi Kumar (Biography
M. N. V. Ravi Kumar

Ravi Kumar is the Professor at Department of Pharmaceutical Sciences, Texas A&M Health Science Center in College Station. His research in drug delivery has won him numerous awards including the British Pharmaceutical Conference Science Medal , UK (2009), Tom Gibson Memorial Award by British Society of Plastic Surgeons & the Royal College of Physicians and Surgeons, UK (2008), Indian National Science Academy (INSA) Medal for Young Scientist, India (2007). He was awarded Alexander von Humboldt Research Fellowship, Germany (2002).

)

Texas A&M Health Science Center
Round Rock, TX
USA

H.A. Santos (Biography
H.A. Santos

Dr. Santos obtained a doctorate (D.Sc.) in Chemical Engineering from the Helsinki University of Technology, Helsinki, Finland. Currently Dr. Santos is an Adjunct Professor in Pharmaceutical Nanotechnology at the University of Helsinki, Finland. He has published more than 150 scientific publications. Dr. Santos serves as Editor and is in the Editorial Board of several international journals.

)

University of Helsinki
Helsinki
Finland

S. Senel
Ankara University
Ankara
Turkey

V.P. Torchilin (Biography
V.P. Torchilin

Vladimir P. Torchilin, Ph.D., D.Sc. is a University Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston. His interests include drug delivery and targeting, nanomedicine, multifunctional and stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy. He has published more than 400 original papers, more than 150 reviews and book chapters, wrote and edited 12 books, and holds more than 40 patents. Google Scholar shows more than 44,000 citations of his papers with H-index of 96. He is Editor-in-Chief of Current Drug Discovery Technologies, Drug Delivery, and OpenNano, Co-Editor of Current Pharmaceutical Biotechnology and on the Editorial Boards of many other journals. He received more than $30 M from the governmental and industrial sources in research funding. He has multiple honors and awards and in 2011, Times Higher Education ranked him number 2 among top world scientists in pharmacology for the period of 2000-2010.

Biography
E. Wagner

Dr. Wagner is professor of Pharmaceutical Biotechnology at Ludwig-Maximilians-Universität Munich and member of the Munich Center for Nanoscience. He coordinates ‘Biomedical Nanotechnologies’ of the Excellence Cluster ‘Nanosystems Initiative Munich’.

After a Ph.D. in Chemistry from the Technical University of Vienna and a postdoctoral stay at the ETH Zurich, he was Group Leader at the IMP Vienna and Director for Cancer Vaccines at Boehringer Ingelheim Austria. Dr. Wagner has authored more than 390 publications (h-index 70). He has been Board member of the German Society for Gene Therapy, Committee member of ASGCT, and BSA member of the CRS.

)

Northeastern University
Boston, MA
USA

E. Wagner (Biography
V.P. Torchilin

Vladimir P. Torchilin, Ph.D., D.Sc. is a University Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston. His interests include drug delivery and targeting, nanomedicine, multifunctional and stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy. He has published more than 400 original papers, more than 150 reviews and book chapters, wrote and edited 12 books, and holds more than 40 patents. Google Scholar shows more than 44,000 citations of his papers with H-index of 96. He is Editor-in-Chief of Current Drug Discovery Technologies, Drug Delivery, and OpenNano, Co-Editor of Current Pharmaceutical Biotechnology and on the Editorial Boards of many other journals. He received more than $30 M from the governmental and industrial sources in research funding. He has multiple honors and awards and in 2011, Times Higher Education ranked him number 2 among top world scientists in pharmacology for the period of 2000-2010.

Biography
E. Wagner

Dr. Wagner is professor of Pharmaceutical Biotechnology at Ludwig-Maximilians-Universität Munich and member of the Munich Center for Nanoscience. He coordinates ‘Biomedical Nanotechnologies’ of the Excellence Cluster ‘Nanosystems Initiative Munich’.

After a Ph.D. in Chemistry from the Technical University of Vienna and a postdoctoral stay at the ETH Zurich, he was Group Leader at the IMP Vienna and Director for Cancer Vaccines at Boehringer Ingelheim Austria. Dr. Wagner has authored more than 390 publications (h-index 70). He has been Board member of the German Society for Gene Therapy, Committee member of ASGCT, and BSA member of the CRS.

)

Ludwig-Maxmillians Universität
Munich
Germany

C. Allen
University of Toronto
Toronto, ON
Canada

P. Cullis (Biography
P. Cullis

Pieter R. Cullis, Ph.D. FRSC, Director, Life Sciences Institute, University of British Columbia; Chair, Personalized Medicine Initiative; Professor, Department of Biochemistry and Molecular Biology, Director, NanoMedicines Research Group, UBC. Dr. Cullis and co-workers have been responsible for fundamental advances in the generation, loading and targeting of lipid nanoparticle (LNP) systems for intravenous delivery of small molecule drugs and macromolecular drugs such as small interfering RNA (siRNA). This work has contributed to three drugs that have been approved by regulatory agencies in the U.S. and Europe for the treatment of cancer and its complications. Dr. Cullis has co-founded ten biotechnology companies, has published over 300 scientific articles and is an inventor on over 60 patents. He also co-founded the BC Personalized Medicine Initiative in 2012, Dr. Cullis has received many awards and was elected a Fellow of the Royal Society of Canada in 2004 and was awarded the Prix Galien, Canada’s premier prize for achievements in pharmaceutical R&D, in 2011.

)

University of British Columbia
Vancouver, BC
Canada

C. Dufès
University of Strathclyde
Glasgow
UK

W.E. Hennink
Utrecht University
Utrecht
The Netherlands

K. Kataoka
University of Tokyo
Tokyo
Japan

Kamla Pathak (Biography
Kamla Pathak

Professor Kamla Pathak, Professor and Head, Department of Pharmaceutics, Pharmacy College Saifai, U. P. RIMS&R, Saifai, Etawah, India has a teaching and research experience of more than 26 years. Actively engaged in research on oral controlled /modulated/targeted and topical drug delivery systems has over 200 publications in journals of international and national repute, 3 patents, authored book chapters and more than 180 abstracts of the papers presented in scientific forums to her credit. She has supervised Ph. Ds, 120+ postgraduate theses and has a h-index of 21.

)

Rajiv Academy for Pharmacy
Uttar Pradesh
India

C. Roberts
University of Nottingham
Nottingham
UK

A. Schatzlein
University of London
London
UK

J. Siepmann (Biography
J. Siepmann

Prof. Juergen Siepmann obtained his Ph.D. in Pharmaceutical Sciences from the Freie Universitaet Berlin, Germany. Since 2004 he is Professor of Pharmaceutical Technology at University of Lille, France. He has published more than 160 articles, is editor of 3 books, author of 16 book chapters, 280 poster and 120 oral presentations and is inventor of 9 patents. Since 2010, he is heading the INSERM research group "Controlled Drug Delivery Systems and Biomaterials" (> 40 scientists) and serves as president of the APGI (International Society of Drug Delivery Sciences and Technology). Prof. Siepmann is currently the Editor‐in‐Chief of the International Journal of Pharmaceutics.

)

University of Lille
Lille
France

K. Uhrich
Rutgers University
Piscataway, NJ
USA

R.B. Walker (Biography
R.B. Walker

Professor Walker completed his Ph.D. degree in Biopharmaceutics and Pharmacokinetics at Rhodes University in Grahamstown, South Africa. He is the former Dean and Head of the Faculty of Pharmacy at Rhodes and is currently the Professor of Pharmaceutics and is the current Chair of the Academy of Pharmaceutical Sciences in South Africa. Professor Walker has published and presented over 200 scientific outputs and serves on the editorial boards of a number of journals. Professor Walker undertakes research studies in all aspects of drug delivery and product development.

)

Rhodes University
Grahamstown
South Africa

S. Allen
University of Nottingham
Nottingham
UK

M. Davies
University of Nottingham
Nottingham
UK

A.T. Florence (Biography
A.T. Florence

Graduating BSc (Pharm) in 1962 and PhD in 1965 from the University of Glasgow and the Royal College of Science and Technology, now Strathclyde University, his first appointment as a lecturer in pharmaceutical chemistry Strathclyde was in 1966 after a year’s postdoctoral work. There followed a year with Karol Mysels in the USA. Returning to Glasgow, he was appointed Senior Lecturer in Pharmaceutical Chemistry in 1972 and J. P. Todd Professor of Pharmaceutics in 1975. After spells as Dean of the School of Pharmacy in Strathclyde and Vice‐Dean of the Faculty of Science. he moved to take up the post of Dean of the School of Pharmacy in the University of London, a post he combined with a research role, from 1989‐2006. Research interests are in surfactant systems, colloids, and aspects of pharmaceutical nanotechnology, particularly the material‐biological interface. He is an editor of the International Journal of Pharmaceutics and was founding co‐editor with Vincent Lee of the Journal of Drug Targeting. He has co‐authored a number of books, the first in 1968 on Solubilization by Surface Active Agents, then with David Attwood, Surfactant Systems (1983), six editions of Physicochemical Principles of Pharmacy (the last published in October 2015), and a solo An Introduction to Clinical Pharmaceutics in 2010.

)

University of London
London
UK

L. Illum (Biography
L. Illum

Professor Lisbeth Illum was the founder and Managing Director of DanBioSyst UK Ltd a drug delivery technology company, sold successfully to West Pharmaceutical Services and now Archimedes Lab Ltd. She was the CEO of Critical Pharmaceuticals Ltd a drug delivery company (sustained release injectable and nasal technologies). She now works as a consultant to the pharmaceutical industry and exert witness in patent litigations.

She was awarded her M. Pharm, Ph. D and D.Sc. from the Royal Danish School of Pharmacy in 1972, 1978 and 1988, respectively. Her research expertise is in the area of novel drug delivery systems for difficult drugs such as hydrophilic and insoluble drugs, peptide and proteins. She has published more than 350 scientific papers, co-edited four books and filed more than 45 patent family applications on novel drug delivery systems, of which a large number of patents has been granted. She has lectured extensively throughout the world at conferences and workshops. She is a Fellow of the AAPS and CRS. She is or has been on the Editorial Boards of eleven scientific journals.

)

IDentity - Pharmaceutical Consultancy
Nottingham
UK

T. Minko (Biography
T. Minko

Tamara Minko, Ph.D., is a Distinguished Professor and Chair of the Department of Pharmaceutics at Rutgers University. Her current research interests include nanotechnology; drug delivery; personalized nanomedicine; molecular targeting; nucleic acids delivery; mechanisms of multidrug resistance; bioimaging; preclinical evaluation of new therapeutics; and modulation of cell death mechanisms during hypoxia. Professor Minko is author and coauthor of more than 400 publications. Dr. Minko is an elected Fellow of CRS, AAPS, and AIMBE; recipient of numerous awards. She also is an Executive Editor of Advanced Drug Delivery Reviews, Editor of Pharmaceutical Research, President-Elect of the Controlled Release Society.

)

Rutgers University
Piscataway, NJ
USA

Q. Peng (Biography
Q. Peng

Dr. Qiang Peng obtained his B.S. degree (2006), M.A. degree (2009), and Ph.D in pharmaceutics (2012) from Sichuan University, China. He joined West China Hospital of Stomatology, Sichuan University as a lecturer in 2012 and promoted as an associate professor in 2014. Dr. Peng once worked in Keele University from 2010 to 2011 and in University of Copenhagen during 2015.

His research focuses on nanomaterials‐based advanced drug delivery. As a young scientist, he has published more than 20 publications. He won the Sichuan Provincial Award of Outstanding PhD Dissertation in 2014 and the First Prize of Chinese Outstanding Young Investigator Award, IADR‐China Division in 2014.

)

Sichuan University
Chengdu
China

S. Salmaso (Biography
S. Salmaso

Stefano Salmaso is associate professor at the Department of Pharmaceutical and Pharmacological Sciences of the University of Padova (Italy), where he teaches Technology of delivery and controlled release of drugs. He obtained his Ph.D. in Pharmaceutical Sciences in 2004 and the Master degree in Chemistry and Pharmaceutical Technology from the University of Padova.

He held positions as assistant professor at the University of Padova and associate scientist at Northeastern University - Boston (USA) in 2005 and 2008. He is author of 58 peerreviewed publications, 3 book chapters, and inventors of 3 international patents.

His scientific activity is focused on the development of responsive “smart” nanocarriers for the delivery of drugs and biopharmaceutics.

)

University of Padova
Padova
Italy

R.M. Schiffelers
Utrecht University
Utrecht
The Netherlands

S.De Smedt (Biography
S.De Smedt

Stefaan C. De Smedt is Director of the Ghent Research Group on Nanomedicines (Belgium); He served as dean of his faculty and is currently a member of the Board of Directors of Ghent University. He has been elected as member of the Belgian Royal Academy of Medicine. Dr. De Smedt serves as the Editor of the Journal of Controlled Release (for Europe- the Middle East & Africa). For his research, which is at the interface between drug delivery, biophysics & material sciences, he received the CRS Young Investigator Award 2006 and the APV Research Award 2010 for Outstanding Research Achievements in Pharmaceutical Sciences. He is a scientific founder of Memobead Technologies and a member of the Drug Delivery Advisory Panel of Santen.

)

Ghent University
Ghent
Belgium

B. Godin Vilentchouk
The Methodist Hospital Research Institute
Houston, TX
USA

S. Wu
University of Toronto
Toronto, ON
Canada


Advertisement

Related Journals




Related eBooks


Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science